SINGAPORE, Aug. 10, 2025 /PRNewswire/ -- HistoIndex, a pioneering leader in digital pathology solutions for chronic liver disease, has announced the launch of FibroSIGHT™ Plus, its second Laboratory Developed Test (LDT) available in the United States. Building on the foundation of...
Hence then, the article about histoindex marks another step forward with fibrosight plus introducing ai based quantitative analysis in fibrosis assessment was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( HistoIndex Marks Another Step Forward with FibroSIGHT™ Plus: Introducing AI-based Quantitative Analysis in Fibrosis Assessment )
Also on site :
- US Crude Oil Inventories Sag As Iran War Bolsters Prices
- HONEYWELL ANNOUNCES PRICING OF HONEYWELL AEROSPACE'S OFFERING OF SENIOR NOTES IN CONNECTION WITH PLANNED SPIN-OFF
- STARZ ENTERTAINMENT CORP. ADOPTS LIMITED DURATION SHAREHOLDER PROTECTION RIGHTS AGREEMENT